Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia

International Journal of Cancer

Volumn 106, Issue 2, 2003, Pages 224-231

  Greiner, Jochen ^a   Ringhoffer, Mark ^a   Taniguchi, Masanori ^a   Hauser, Thomas ^a   Schmitt, Anita ^a   Döhner, Hartmut ^a   Schmitt, Michael ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Acute myeloid leukemia; Chronic myeloid leukemia; Leukemia associated antigens; MPP11; SEREX

Indexed keywords

BRCA1 ASSOCIATED PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN HSJ2; IMMUNOGLOBULIN G ANTIBODY; J KAPPA RECOMBINATION BINDING PROTEIN; LEUKEMIA ANTIGEN; M PHASE PHOSPHOPROTEIN II; MESSENGER RNA; PHOSPHOPROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BREAST CARCINOMA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE LIBRARY; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOTHERAPY; KIDNEY CARCINOMA; MELANOMA; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; SOLID TUMOR; TESTIS; UPREGULATION; VACCINATION;

ACUTE DISEASE; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CARCINOMA, RENAL CELL; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION; HUMANS; K562 CELLS; KIDNEY NEOPLASMS; LEUKEMIA, MYELOID, CHRONIC; NEOPLASM PROTEINS; ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS;

EID: 0038493639     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11200     Document Type: Article

References (38)

1. Bonifazi F, de Vivo A, Rosti G, Guilhot F, Guilhot J, Trabacchi E, Hehlmann R, Hochhaus A, Shepherd PC, Steegmann JL, Kluin-Nelemans HC, Thaler J, Simonsson B, Louwagie A, Reiffers J, Mahon FX, Montefusco E, Alimena G, Hasford J, Richards S, Saglio G, Testoni N, Martinelli G, Tura S, Baccarani M. Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders. Blood 2001;98:3074-81.
2. Hochhaus A, Reiter A, Saußele S, Reichert A, Emig M, Kaeda J, Schultheis B, Berger U, Shepherd PCA, Allan H, Hehlmann R, Goldman JM, Cross NCP, for the German CML Study Group and the UK MRC CML Study Group. Molecular heterogeneity in complete cytogenetic responders after interferon-α therapy for chronic myeloid leukemia: low levels of minimal residual disease are associated with continuing remission. Blood 2000;95:62-6.
3. Kolb HJ, Mittermüller J, Clemm C, Holler E, Ledderose G, Brehm G, Heim M, Wilmanns W. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990;76:2462-5.
4. Falkenburg JH, Wafelman AR, Joosten P, Smit WM, van Bergen C, Bongaerts R, Lurvink E, van der Hoorn M, Kluck P, Landegent JE, Kluin-Nelemans HC, Fibbe WE, Willemze R. Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes. Blood 1999;94:1201-8.
5. Kolb KJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermüller J, de Witte T, Holler E, Ansari H. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995;86:12041-50.
6. Porter DL, Roth MS, McGarigle C, Ferrara JL, Antin JH. Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation. N Engl J Med 1994;330:100-6.
7. Collins RH Jr, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R, Goodman SA, Wolff SN, Hu W, Verfaillie C, List A, Dalton W, Ognoskie N, Chetrit A, Antin JH, Nemunaitis J. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997;15:416-7.
8. Türeci Ö, Sahin U, Vollmar E, Siemer S, Gottert E, Seitz G, Parkkila AK, Shah GN, Grubb JH, Pfreundschuh M, Sly WS. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overespressed in some renal cancers. Proc Natl Acad Sci 1998;95:7608-13.
9. Sahin U, Türeci Ö, Pfreundschuh M. Serological identification of human tumor antigens. Curr Opin Immunol 1997;9:709-16.
10. Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Türeci Ö, Sahin U, Pfreundschuh M, Old LJ. Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 1998;76:652-8.
11. Bossone SA, Asselin C, Patel AJ, Marcu KB. MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination. Proc Natl Acad Sci 1992;89:7452-6.
12. Song J, Murakami H, Tsutsui H, Tang X, Matsumura M, Itakura K, Kanazawa I, Sun K, Yokoyama KK. Genomic organization and expression of a human gene for myc-associated zinc finger protein (MAZ). J Biochem 1998;273:20603-14.
13. Greiner J, Ringhoffer M, Simikopinko O, Szmaragowska A, Maurer U, Bergmann L, Schmitt M. Simultaneous expression of different immunogenic antigens in acute myeloid leukemia (AML). Exp J Hematol 2000;28:1413-22.
14. Ling M, Wen YJ, Lim SH. Prevalence of antibodies against proteins derived from leukemia cells in patients with chronic myeloid leukemia. Blood 1998;92:4764-70.
15. Yang X-F, Wu C, McLaughlin S, Chillemi A, Wang KS, Canning C, Alyea EP, Kantoff P, Soiffer RJ, Dranoff G, Ritz J. CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia. Proc Nat Acad Sci 2001;98:7492-7.
16. Wu C, Yang X-F, McLaughlin S, Neuberg D, Canning C, Stein B, Alyea EP, Soiffer RJ, Dranoff G, Ritz J. Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia. J Clin Invest 2000;106:705-14.
17. Greiner J, Ringhoffer M, Taniguchi M, Schmitt A, Kirchner D, Krähn G, Heilmann V, Gschwend J, Bergmann L, Döhner H, Schmitt M. RHAMM is a new immunogenic leukemia-associated antigen overexpressed in acute and chronic myeloid leukemia. Exp J Hematol 2002;30:1029-35.
18. Okada H, Attanucci J, Giezeman-Smits KM, Brissette-Storkus C, Fellows WK, Gambotto A, Pollack IF, Poque-Geile K, Lotze MT, Bozik ME, Chambers WH. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat9L glioma in vivo. Cancer Res 2001;61:2625-31.
19. + T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity. Cancer Res 2000;60:2449-57.
20. Bergmann L, Miething C, Maurer U, Brieger J, Karakas T, Weidmann E, Hoelzer D. High levels of Wilms' tumor gene (wtl) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 1997;90:1217-25.
21. + progenitors. Blood 1997;90:4230-2.
22. Molldrem J, Dermime S, Parker K, Jiang YZ, Mavroudis D, Hensel N, Fukushima P, Barrett J. Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. Blood 1996;88:2450-7.
23. Molldrem J, Lee PP, Wang C, Champlin RE, Davis MM. A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myeloid leukemia. Cancer Res 1999;59:2675-81.
24. Dengler R, Münstermann U, Al-Batran S, Hausner I, Faderl S, Nerl C, Emmerich B. Immunocytochemical and flow cytometric detection of proteinase 3 (myeloblastin) I normal and leukaemic myeloid cells. Br J Haematol 1995;89:250-7.
25. Li S, Ku C, Farmer AA, Cong Y, Chen C, Lee W. Identification of a novel cytoplasmatic protein that specifically binds to nuclear localization signal motifs. J Biol Chem 1998;273:6183-9.
26. Robson M, Gilewski T, Haas B, Levin D, Borgen P, Rajan P, Hirschaut Y, Pressman P, Rosen PP, Lesser ML, Norton L, Offit K. BRCA-associated breast cancer in young women. J Clin Oncol 1998;16:1642-9.
27. Miki Y, Swensen J, Shattuck-Eidens D. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA-1. Science 1994;266:120-2.
28. Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jäger D, Jäger E, Knuth A, Chen YT, Old LJ. Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer 1999;83:456-64.
29. Soti C, Csermely P. Molecular chaperones in the etiology and therapy of cancer. Pathol Oncol Res 1998;4:316-21.
30. Sato K, Torimoto Y, Tamura Y, Shindo M, Shinzaki H, Hirai K, Kohgo Y. Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice. Blood 2001;98:1852-7.
31. Albani S, Keystone EC, Nelson JL, Ollier WER, La Cava A, Montemayor AC, Weber DA, Montecucco C, Martini A, Carson DA. Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nat Med 1995;5:448-52.
32. Shoji W, Inoue T, Yamamoto T, Obinata M. MIDA1, a protein associated with ID, regulates cell growth. J Biol Chem 1995;270:24818-25.
33. Inoue T, Shoji W, Obinata M. MIDA1, an Id-associating protein, has two distinct DNA binding activities that are converted by the association with Id1: a novel funtion of Id protein. Biochem Biophys Res Commun 1999;266:147-51.
34. Inoue T, Shoji W, Obinata M. MIDA1 is a sequence specificDNA binding protein with novel DNA binding properties. Genes Cells 2000;5:699-709.
35. Resto VA, Caballero OL, Buta MR, Westra WH, Wu L, Westendorf JM, Jen L, Hieter P, Sidransky D. A putative oncogenic role for MPP11 in head and neck squamous cell cancer. Cancer Res 2000;60:5529-35.
36. Gure AO, Stockert E, Scanlan MJ, Keresztes RS, Jager D, Altorki NK, Old LJ, Chen YT. Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc Natl Acad Sci USA 2000;97:4198-203.
37. Scanlan MJ, Gout I, Gordon CM, Williamson B, Stockert E, Gure AO, Jäger D, Chen YT, Mackay A, O'Hare MJ, Old LJ. Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer Immun 2001;1:4-10.
38. Yan W, Schilke B, Pfund C, Walter W, Kim S, Craig EA. Zuotin, a ribosome-associated Dnaj molecular chaperone. EMBO J 1998;17:4809-17.